News

Interview: Seekyo's CEO insights on Targeting The Microenvironment as a new approach (Nov 2025)

In the Press: Seekyo's CEO insights: "investors stick to basics at BIO 2025" (June 2025)

Interview: Seekyo's CEO insights on Targeting The Microenvironment (June 2025)

In the press: Seekyo's CEO sharing his insights with Global Data - Clinical Trials (March 2025)

In the Press: Seekyo developing today the tomorrow's treatments (Nov 2024)

In the Press: Seekyo's CEO sharing his perspective with Drug Discovery World (Feb 2025)

Seekyo is adding diagnostics and theranostics capabilities to its lead compound SKY01 (March 2022)

Seekyo raises 650k€ with leverage effect (March 2021)

Seekyo raises €800k with leverage effect (Janv 2020)

Seekyo: A major advance against Cancer fight

Media